首页|期刊导航|中国神经再生研究（英文版）|Should mast cells be considered therapeutic targets in multiple sclerosis?

Should mast cells be considered therapeutic targets in multiple sclerosis?

Karen Henriette Pinke Vanessa Soares Lara Alexandrina Sartori

中国神经再生研究（英文版）2020，Vol.15Issue(11)：1995-2007,13.

中国神经再生研究（英文版）2020，Vol.15Issue(11)：1995-2007,13.DOI:10.4103/1673-5374.282238

Should mast cells be considered therapeutic targets in multiple sclerosis?

Karen Henriette Pinke ¹Vanessa Soares Lara ²Alexandrina Sartori¹

作者信息

1. Institute of Biosciences,Department of Microbiology and Immunology,São Paulo State University (UNESP),Botucatu,São Paulo,Brazil
2. Bauru School of Dentistry,Department of Surgery,Stomatology,Pathology and Radiology,University of São Paulo,Bauru,São Paulo,Brazil
折叠

摘要

关键词

central nervous system/degenerative disease/experimental autoimmune encephalomyelitis/immunity/immunomodulatory drugs/inflammatory disease/ketotifen fumarate/mast cells/multiple sclerosis/therapeutic target

Key words

引用本文复制引用

Karen Henriette Pinke,Vanessa Soares Lara,Alexandrina Sartori..Should mast cells be considered therapeutic targets in multiple sclerosis?[J].中国神经再生研究（英文版）,2020,15(11):1995-2007,13.

基金项目

This work was supported by S?o Paulo Research Foundation(FAPESP,grant Nos.2015/03965-2 and 2014/00239-6),the National Council for Scientific and Technological Development(CNPq,grant Nos.307603/2018-0 and 307269/2017-5),and Coordination for the Improvement of Higher Education Personnel(CAPES,Finance Code 001). （FAPESP,grant Nos.2015/03965-2 and 2014/00239-6）

中国神经再生研究（英文版）

OACSCDCSTPCDSCI

ISSN：1673-5374

访问量0

下载量0

段落导航